AbbVie (ABBV) Return on Assets [ROA] (2013 - 2026)
AbbVie (ABBV) posted Return on Assets [ROA] of 4.65% for Q2 2026, up 1.89 percentage points from 2.76% a year earlier and up 1.96 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025, AbbVie's Return on Assets [ROA] came in at 3.15%, down 0.03 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -0.71 percentage points (FY2020 to FY2025).
- In prior years, AbbVie's Return on Assets [ROA] was 3.18% in FY2024 (-0.39 pp), 3.56% in FY2023 (-4.74 pp), 8.30% in FY2022 (+0.53 pp) and 7.77% in FY2021 (+3.92 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q3 2023.
- On a year-over-year basis, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -0.51 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2022, with a gain of 5.19 percentage points; the weakest was Q4 2023, with a drop of 4.86 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 2.69% (Q1 2026), 3.16% (Q4 2025) and 1.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 10.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.65% |
| Mar 31, 2026 | 2.69% |
| Dec 31, 2025 | 3.16% |
| Sep 30, 2025 | 1.77% |
| Jun 30, 2025 | 2.76% |
| Mar 31, 2025 | 3.10% |
| Dec 31, 2024 | 3.08% |
| Sep 30, 2024 | 3.60% |
| Jun 30, 2024 | 3.68% |
| Mar 31, 2024 | 4.23% |
| Dec 31, 2023 | 3.60% |
| Sep 30, 2023 | 4.80% |
| Jun 30, 2023 | 6.44% |
| Mar 31, 2023 | 5.56% |
| Dec 31, 2022 | 8.46% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | 8.83% |
| Mar 31, 2022 | 8.62% |
| Dec 31, 2021 | 7.82% |
| Sep 30, 2021 | 5.08% |
API Access
AbbVie Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();